Invited Commentary
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19

https://doi.org/10.1016/j.jamcollsurg.2020.05.021Get rights and content

Cited by (0)

Disclosure Information: Dr Neal has received research support and personal fees from Janssen Pharmaceuticals and Haemonetics. He receives research support from Instrumentation Labs and Noveome. He serves on the Scientific Advisory Board of Haima Therapeutics.

Support: Dr Neal receives research support from the NIH/NIGMS and the Department of Defense (R35GM119526-05).

View Abstract